Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s ...

The Chinese herbal medicine company says it has a proprietary formula that can help treat ADHD and autism. There are a handful of factors that can explain the stock's mysterious climb. Shares of a ...

Regencell Bioscience Holdings, a Hong Kong-based firm specializing in traditional Chinese medicine, saw its US-listed stock soar 398% over the first two days of the week.

Editas Medicine , Inc. (NASDAQ: EDIT), a biotechnology company based in Cambridge, Massachusetts, announced several key developments following its annual meeting of stockholders held on May 29, 2025.

Prime Medicine is progressing with in vivo programs targeting Wilson’s Disease and Alpha-1 Antitrypsin Deficiency (AATD), with expectations to file an investigational new drug (IND) and/or ...

The Brigham Young University Board of Trustees has approved the BYU West Campus, site of the former Provo High School, as the location for the future BYU School of Medicine building. This site on the ...

Stock markets have been hammered by President Trump’s sweeping tariffs, which he insists will eventually revitalize the American economy. Jon Stewart had a different take on Monday’s “Daily ...

Mind Medicine (NASDAQ: MNMD) stock is seeing impressive gains Friday. The company's share price was up 16.9% as of 3:15 p.m. ET and had been up as much as 20.7% on the day earlier in the session ...

Mind Medicine (NASDAQ: MNMD) stock is posting big gains in Tuesday's trading. The biotech company's share price was up 8.7% as of 2 p.m. ET despite a 0.8% pullback for the S&P 500 index and a 1.5% ...

Clearmind Medicine's stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcohol use disorder.